India Glycols schedules analyst meetings and roadshow for Oct 7-8
- India Glycols scheduled analyst meetings for October 7 and 8, 2026
- Events include a non-deal meeting and a roadshow in Mumbai
- Discussions restricted to publicly available information only

*this image is generated using AI for illustrative purposes only.
India Glycols Limited has scheduled a series of interactions with analysts and institutional investors for October 7 and 8, 2026. The events include a non-deal meeting and a roadshow, both set to take place in Mumbai.
The company filed this intimation with BSE Limited and the National Stock Exchange of India Limited on October 1, 2026, pursuant to Regulation 30 of the SEBI Listing Regulations. The disclosure outlines the specific dates and modes of engagement planned for the upcoming week.
Meeting Schedule Details
The following table details the planned events as disclosed by the company:
| Day & Date | Event | Mode of Meeting | Location |
|---|---|---|---|
| Wednesday, October 7, 2026 | Non-Deal | In-Person | Mumbai |
| Thursday, October 8, 2026 | Roadshow | Not Specified | Not Specified |
The company noted that changes to the schedule may occur due to exigencies on the part of participants, hosts, or the company itself.
Disclosure Guidelines
India Glycols emphasized that all discussions during these interactions will be based strictly on publicly available information. The company explicitly stated that no unpublished price sensitive information (UPSI) is intended to be discussed during the sessions. This ensures compliance with regulatory standards regarding fair disclosure to all market participants.
The intimation letter was signed by Ankur Jain, Head (Legal) & Company Secretary. The document is also hosted on the company's official website for public access.
Historical Stock Returns for India Glycols
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.80% | +15.95% | -74.64% | -64.80% | -65.18% | -26.11% |
How might the insights shared during the October 2026 roadshow influence India Glycols' stock valuation in the subsequent quarter?
What specific growth strategies or capital expenditure plans are institutional investors likely to scrutinize during these non-deal meetings?
Will the engagement with analysts lead to any revisions in consensus earnings estimates for India Glycols for FY27?


































